Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Baker

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Seminars in Surgical Oncology|July 1, 1994
Etiology, biology, and epidemiology of ovarian cancerT R Baker, M S Piver
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1974
Ocular findings in multiple myeloma. A report of two casesT R Baker, W H Spencer
Pediatric Annals|July 1, 1986
Cervical cancer in the adolescent patientM S Piver, T R Baker
American Journal of Clinical Oncology|June 1, 1991
Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinomaM S Piver, J Fanning, T R Baker
American Journal of Clinical Oncology|August 1, 1995
Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trialR E Hempling, M S Piver, T R Baker
European Journal of Gynaecological Oncology|January 1, 1990
Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapyM S Piver, T R Baker, D L Driscoll
European Journal of Gynaecological Oncology|January 1, 1993
Response to Taxol chemotherapy in resistant ovarian carcinomaT R Baker, M S Piver, R E Hempling
Cancer|July 15, 1994
Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinomaT R Baker, M S Piver, R E Hempling
European Journal of Gynaecological Oncology|January 1, 1993
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinomaT R Baker, M S Piver, R E Hempling
American Journal of Clinical Oncology|June 1, 1991
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovaryT R Baker, M S Piver, H Caglar, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Seminars in Surgical Oncology|July 1, 1994
Etiology, biology, and epidemiology of ovarian cancerT R Baker, M S Piver
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1974
Ocular findings in multiple myeloma. A report of two casesT R Baker, W H Spencer
Pediatric Annals|July 1, 1986
Cervical cancer in the adolescent patientM S Piver, T R Baker
American Journal of Clinical Oncology|June 1, 1991
Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinomaM S Piver, J Fanning, T R Baker
American Journal of Clinical Oncology|August 1, 1995
Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trialR E Hempling, M S Piver, T R Baker
European Journal of Gynaecological Oncology|January 1, 1990
Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapyM S Piver, T R Baker, D L Driscoll
European Journal of Gynaecological Oncology|January 1, 1993
Response to Taxol chemotherapy in resistant ovarian carcinomaT R Baker, M S Piver, R E Hempling
Cancer|July 15, 1994
Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinomaT R Baker, M S Piver, R E Hempling
European Journal of Gynaecological Oncology|January 1, 1993
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinomaT R Baker, M S Piver, R E Hempling
American Journal of Clinical Oncology|June 1, 1991
Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovaryT R Baker, M S Piver, H Caglar, et al.
Pageof 6